Heart Health

This news channel includes content on cardiovascular disease prevention, cardiac risk stratification, diagnosis, screening programs, and management of major risk factors that include diabetes, hypertension, diet, life style, cholesterol, obesity, ethnicity and socio-economic disparities.

CES 2025: Cardiologist check-ups, AI-powered smart mirrors coming to heart patients’ homes
Healthcare companies from all over the world are showing off their newest cardiovascular offerings at CES 2025 in Las Vegas.
Semaglutide linked to ‘significant and consistent’ benefits for heart bypass surgery patients
The popular GLP-1 receptor agonist appears to help limit adverse events and new-onset diabetes in patients with a history of CABG. Researchers shared the full study in the Journal of the American College of Cardiology.
The best diets for heart health: DASH diet surpasses Mediterranean, MIND, vegan and flexitarian options
Experts say the DASH diet, designed to lower blood pressure and improve heart health, is fairly flexible and associated with several key benefits.
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders
The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.
Merck spends up to $2B to license new weight loss drug with potential heart benefits
Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.

FDA announces yet another new recall for extended-release metformin due to contamination

This is the second voluntary recall for extended-release metformin of 2021.

January 29, 2021

Diabetes, insulin resistance strongly associated with premature coronary heart disease among women

The study’s authors explored data from more than 28,000 women, focusing on the impact of dozens of biomarkers.

January 22, 2021

Empagliflozin provides additional benefits to patients with type 2 diabetes and CAD

The authors found a link between six months of empagliflozin and a reduction in extracellular volume, sharing their findings in JACC: Cardiovascular Imaging.

January 18, 2021

A real update on artificial sweeteners: Saccharin does not lead to diabetes in healthy adults

Researchers explained that their findings were different from previous studies because they took a wide variety of factors, including underlying health conditions, into account.

January 14, 2021

Cardiologist urges patients not to follow keto diet, calling it ‘a mistake’

“The keto diet, I believe, is based on misinformation," he said.

January 13, 2021

Motion sensors confirm that staying active lowers your risk of CVD—and the more you move, the lower the risk

Researchers turned to accelerometers, lightweight motion sensors that can be attached to a user’s wrist, to investigate this topic.

January 12, 2021

Patients with advanced chronic kidney disease should keep taking RAS inhibitors

Researchers explored the controversial topic in the Journal of the American Society of Nephrology.

January 4, 2021

Skip the meat? Considering the cardiovascular benefits of pescatarian, vegetarian diets

Vegetarian diets must still contain heart-healthy choices, the researchers wrote—simply doing away with meat is not enough to turn around your health.

December 23, 2020

Heart Health

CES 2025: Cardiologist check-ups, AI-powered smart mirrors coming to heart patients’ homes

Semaglutide linked to ‘significant and consistent’ benefits for heart bypass surgery patients

The best diets for heart health: DASH diet surpasses Mediterranean, MIND, vegan and flexitarian options

FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

Merck spends up to $2B to license new weight loss drug with potential heart benefits